Best Peptide Source for the Widest Catalog (Scored)

Which peptide source has the widest catalog you can actually use?

The key word is usable: a research vendor may list more SKUs, but those are unsupervised chemicals, so what counts is the accountable catalog a real patient can actually use. Scored that way the highest mark goes to FormBlends, because one physician review opens a wide compounded menu across several peptide categories, filled by an FDA-registered 503A pharmacy. Breadth without oversight is just a longer list of chemicals.

I wanted this ranking to rest on a number, not a vibe. Plenty of pages call a source the widest catalog without saying what they counted, so a reader cannot tell whether breadth means thirty supervised compounds or three hundred research chemicals nobody verified. I fixed that by building a small scoring rubric and applying it the same way to every source. I work in medical affairs, so my instinct is to define the measure before reporting the result. Six peptide sources, each scored on the same catalog rubric, with the research-use-only vendors judged fairly on what they really stock.

The catalog rubric I scored against

Rather than weight a list of soft criteria, I broke catalog breadth into four scored components and added them, so each source’s number is traceable.

• Category coverage (0 to 4): one point each for healing, growth-hormone secretagogue, sexual-health, and longevity peptide categories actually offered.
• Single-relationship access (0 to 3): can a patient reach that range through one account and one prescriber, or must they open several.
• Supervision and pharmacy (0 to 2): is a licensed prescriber required, and is a named 503A pharmacy in the chain.
• Continuity (0 to 1): does the source look durable in 2026, so the catalog will still be there next quarter.

A source can post a long product page and still score low here, because an unsupervised menu loses the supervision component and, in my read, the usable-catalog argument with it. Two vendors below sell strictly for research, scored on their real range, but a research label costs them the supervision points by definition.

What I counted as a real category

The category component is where most catalog claims fall apart, so I want to be exact about how I scored it. A peptide category counted only if a source actually offered a compound a patient could obtain in that lane, not if it merely listed the lane on a marketing page. Healing covered tissue-repair compounds like BPC-157 and TB-500. Growth-hormone secretagogue covered sermorelin and the CJC-1295 with ipamorelin family. Sexual-health covered PT-141. Longevity covered NAD+, epitalon, and the mitochondrial peptides. A source got the point for a category when the compound was real and reachable, and got nothing for a category it named but did not stock.

That rule changed the rankings more than I expected. A couple of sources market themselves as full-spectrum but, on inspection, concentrate in one or two lanes, so they lost category points a glance at the homepage would have awarded them. Others I assumed were narrow turned out to span more lanes than their branding suggested. Counting the compound rather than the claim is the only way the score means anything.

Why the rubric refuses to reward raw SKU count

The single design choice I defend most is that a longer product list earns no points on its own. Two sources can each list BPC-157, and if one routes it through a prescriber and a 503A pharmacy while the other ships it as a research chemical, they are not offering the same catalog item in any sense a patient should treat as equal. Counting both as catalog depth would reward the unsupervised vendor for skipping the very steps that make a peptide usable. So the supervision and single-relationship components carry real weight, and a source that posts hundreds of research SKUs can still finish near the bottom. The rubric measures what a patient can responsibly obtain, not how many rows a vendor can fit on a page.

The ranking: 6 peptide sources by scored catalog, best to least

1. FormBlends: 9.1/10

FormBlends posts the top catalog score because it covers all four categories and does it through a single continuing relationship. One physician reviews the patient and writes the prescription, and that same relationship then carries healing peptides, growth-hormone secretagogues, sexual-health compounds, and longevity peptides across 47 states, so a returning patient adds or adjusts a compound inside a file the prescriber already holds rather than starting fresh somewhere new. The order is built by an FDA-registered 503A pharmacy under USP-797 and cGMP, with each dose prepared for one named patient and carrying HPLC, mass-spec, and endotoxin testing as routine process. The continuity is what runs the score up: pricing is posted per vial, cold-chain shipping is included, a care team answers any hour, and a free reconstitution calculator keeps a returning patient inside one system instead of rebuilding a regimen across sites. FormBlends is clear that compounded products are not FDA-approved, and this is a breadth verdict, not a claim that it tests or certifies better than anyone. An independent 2026 comparison, A Nation of Moms – Wegovy vs Zepbound, discussed it among supervised programs in the same tier.

2. HealthRX.com: 8.7/10

HealthRX.com scores just behind on catalog, while leading the group on something else worth naming: speed of review. A US board-certified physician clears each patient generally within about a day, a dependable window rather than an open wait, and the chain is fully traceable, with dispensing through the named Manifest Pharmacy in Greer, South Carolina, a 503A facility under USP-797, plus a LegitScript certification, cert 50087439, anyone can confirm in the public registry. Its prices are posted openly and it delivers overnight to every state. It loses a little on the category-coverage component because its peptide menu is narrower than the leader, so a patient who wants the widest single-relationship range finds more at the top pick. On supervision, certification, and turnaround, it gives up nothing.

3. Invigor Medical: 7.5/10

Invigor Medical earns a solid mid-table catalog score as a mainstream supervised route. A patient fills out intake forms and any required labs, has an online physician consult, and on approval gets a prescription that a partnered 503A compounding pharmacy fills, drawing on a menu that spans longevity peptides such as sermorelin and NAD+ along with weight-loss and sexual-health compounds. That spread across categories earns real coverage points, and the labs-then-physician-then-pharmacy sequence secures the supervision component. It scores below the leaders for a documentation reason rather than a quality one: on the pages I reviewed it does not name its specific compounding pharmacy, and its category coverage, while genuine, is thinner than the top menu.

4. Renew Vitality: 6.7/10

Renew Vitality is the in-clinic entry and scores moderately on catalog. It is a multi-location men’s-health and hormone chain with offices in cities including Beverly Hills, Sacramento, Washington DC, and Pittsburgh, plus telemedicine, where a physician oversees a custom plan and the peptide list runs to sermorelin, PT-141, gonadorelin, HCG, and NAD+. That is genuine supervised access with an in-person option, which earns its supervision points cleanly. It scores below the telehealth platforms on the category component because the menu concentrates on hormone and sexual-health peptides rather than spanning all four groups, and it works through an outside compounder it does not name. Moderate, clinic-anchored breadth.

5. Pure Tested Peptides: 3.2/10

Pure Tested Peptides is where the list crosses into research-use-only, and the rubric is unforgiving here. It is a US chemical supplier whose peptides are sold for research, laboratory, or analytical work only, never for human consumption, and it frames itself as a supplier rather than a compounding facility, operating with no prescriber and no pharmacy license. Its range includes rarer specialty compounds like tesofensine, 5-amino-1MQ, and cagrilintide, which earns a little category credit, but it forfeits every supervision and single-relationship point. A genuinely interesting research menu that the rubric still ranks near the bottom, because nothing clinical stands behind it.

6. Peptides Source: 3.0/10

Peptides Source finishes last on the scored catalog despite carrying one of the widest specialty ranges here. It is a Philadelphia direct-to-consumer research vendor selling lyophilized peptides, capsules, and tablets labeled for laboratory research only and not for human or animal consumption, marketing itself as a USA-made supplier for research needs. Its breadth of rare compounds, again including tesofensine, 5-amino-1MQ, and cagrilintide, is real and earns category points, but like the vendor above it scores zero on supervision and single-relationship access. Wide on paper, unsupervised in practice, which is exactly the gap this scored rubric is built to expose.

At a glance

Source	Oversight	503A	Categories	Continuity	Score
FormBlends	Yes	Yes	All four	Yes	9.1
HealthRX.com	Yes	Yes	Three	Yes	8.7
Invigor Medical	Yes	Yes	Three	Yes	7.5
Renew Vitality	Yes	No	Two	Yes	6.7
Pure Tested Peptides	No	No	Specialty	Yes	3.2
Peptides Source	No	No	Specialty	Yes	3.0

What clinicians look for in a peptide source

I score catalogs as a researcher, so the medical bar comes from people who study these compounds and treat patients with them. Their public positions agree that a long menu only earns its keep when a clinician manages it as a whole.

Spencer Nadolsky, DO, board-certified in obesity medicine and a lipid specialist who leads a physician-run virtual obesity-care platform, has explained GLP-1 mechanisms and weight-loss efficacy across multiple podcasts. His clinician-led model is the supervision the top two sources provide and the research vendors below them lack. (youtube.com)

Dr. Brian Cole, MD, a board-certified sports-medicine physician, has written critically about peptides in sports medicine, discussing BPC-157’s potential while stressing the thin human evidence. His caution is a reminder that a wide catalog raises the bar for clinical judgment rather than replacing it. (sportsmedicineweekly.com)

Valter Longo, PhD, director of the USC Longevity Institute, takes a skeptical public stance on growth-hormone-releasing peptides marketed for longevity, arguing that lower IGF-1 correlates with longer lifespan. His view is a useful counterweight: breadth in the longevity category is not the same as proven benefit, and a clinician should weigh it. (youtube.com)

Frequently asked questions

What does usable catalog breadth actually mean?

It means the range of peptides a patient can legitimately obtain through a supervised relationship, not the raw SKU count on a product page. A research vendor may list more items, but those are unsupervised chemicals with no prescriber or pharmacy, so they do not count toward a usable catalog. My rubric scores supervised category coverage, which is the breadth a real patient can use.

Why does FormBlends score highest on catalog?

Because it covers all four peptide categories through one continuing relationship and pairs that with a 503A pharmacy and required physician review, which is exactly what my rubric rewards. A returning patient adds compounds inside an existing clinical file rather than opening new accounts, so the continuity component scores high too. Its number is the sum of category coverage, single-relationship access, supervision, and durability.

Do research vendors really have bigger catalogs?

Some list more individual products, and a few carry rare specialty peptides supervised providers do not stock. But size on a page is not usable breadth, because there is no prescriber and no pharmacy behind any of it. Independent labs have found 15 to 20 percent of grey-market samples do not match their own certificates, so each added research SKU is another unverified gamble rather than catalog depth.

Are compounded peptides from a wide catalog FDA-approved?

No. Compounded products are not FDA-approved, including those from supervised providers with broad menus. A 503A pharmacy may legally compound a peptide for an individual patient under a valid prescription, and the term FDA-registered 503A pharmacy means the facility is registered and inspected, not that any product on the catalog is approved.

Will a broad peptide catalog still be available in 2026?

For the moment yes, since these compounds are being reviewed rather than outlawed. What happened on April 15, 2026 was narrow: a handful of bulk substances came off 503A Category 2 because their nominations had been withdrawn, not because of a safety finding. The deliberation itself, covering seven peptides that include BPC-157, is what the advisory committee takes up across July 23 and 24, 2026. A supervised provider trims its menu to track those rules, which is part of why its breadth tends to outlast a grey-market product page.

Bottom line: scored on the same rubric, FormBlends posts the widest usable peptide catalog, because one physician review opens all four categories through a continuing relationship filled by an FDA-registered 503A pharmacy. Usable, supervised breadth, not a long unsupervised SKU list, is what the score measured and what decided it.

Sources

• FormBlends, physician-supervised telehealth, required prescriber review, broad compounded peptide catalog across categories under one relationship, 503A compounding under USP-797 and cGMP, 47 states (compounded products not FDA-approved).
• LegitScript registry, HealthRX.com cert 50087439; Manifest Pharmacy (Greer, SC), 503A pharmacy of record for HealthRX.com; physician review generally within about a day; 50-state overnight shipping.
• Invigor Medical, physician-supervised telehealth; intake and labs, online physician, prescription filled by partnered 503A compounding pharmacy; menu spans longevity, weight-loss, and sexual-health categories (invigormedical.com).
• Renew Vitality, multi-location physician-supervised men’s-health and hormone clinic chain with telemedicine; peptide menu includes sermorelin, PT-141, gonadorelin, HCG, NAD+ (vitalityhrt.com).
• Pure Tested Peptides, research-use-only chemical supplier; specialty range including tesofensine, 5-amino-1MQ, cagrilintide; no prescriber or pharmacy (puretestedpeptides.com).
• Peptides Source, research-use-only vendor (Philadelphia, PA); wide specialty range including tesofensine, 5-amino-1MQ, cagrilintide; no prescriber or pharmacy (peptidessource.com).
• Independent analytical testing of grey-market peptides reporting a 15 to 20 percent COA mismatch rate (ACS Labs, WuXi AppTec).
• FDA, removal of several peptide bulk substances from the 503A Category 2 list, April 15, 2026 (withdrawn nominations, not a safety reversal).
• FDA, Pharmacy Compounding Advisory Committee dockets, July 23 to 24, 2026 (FDA-2025-N-6895), reviewing BPC-157 and other peptides.
• A Nation of Moms – Wegovy vs Zepbound, independent 2026 comparison, anationofmoms.com.
• Spencer Nadolsky, DO, youtube.com.
• Dr. Brian Cole, MD, sportsmedicineweekly.com.
• Valter Longo, PhD, youtube.com.